Novartis India Limited (BOM:500672)

Novartis India Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	931.8	1,009	851.9	1,034	-37.2
Depreciation & Amortization	19.5	21.9	26.1	60.6	96.5
Loss (Gain) From Sale of Assets	0.3	-1.1	-32.1	-28.9	1.4
Stock-Based Compensation	2.7	3.3	2.5	3.8	18.5
Provision & Write-off of Bad Debts	-1.3	-1.7	1.7	3.7	-3.6
Other Operating Activities	-346.6	-278.1	193.5	-384.8	-356.1
Change in Accounts Receivable	32.2	15	-53.4	80.3	-42
Change in Inventory	-122.1	37.5	98.6	23.5	-91.2
Change in Accounts Payable	21.8	-92.5	21.2	-100.2	148.3
Change in Other Net Operating Assets	-71	32.4	24	-243.6	652.1
Operating Cash Flow	467.3	745.7	1,134	448	386.7
Operating Cash Flow Growth	-37.33%	-34.24%	153.13%	15.85%	-
Capital Expenditures	-3.4	-	-	-3.1	-5
Sale of Property, Plant & Equipment	0.2	3.2	32.7	39.4	-
Investment in Securities	-200.2	-449	-48.3	-1,769	720
Other Investing Activities	379.7	412.7	346.9	199.8	155.4
Investing Cash Flow	176.3	-33.1	331.3	-1,533	870.4
Long-Term Debt Repaid	-22	-24.1	-37	-57.4	-109
Net Debt Issued (Repaid)	-22	-24.1	-37	-57.4	-109
Common Dividends Paid	-617.3	-617.3	-1,173	-246.9	-246.9
Other Financing Activities	-	-0.1	-0.1	-0.5	-0.4
Financing Cash Flow	-639.3	-641.5	-1,210	-304.8	-356.3
Net Cash Flow	4.3	71.1	255.4	-1,389	900.8
Free Cash Flow	463.9	745.7	1,134	444.9	381.7
Free Cash Flow Growth	-37.79%	-34.24%	154.89%	16.56%	-
Free Cash Flow Margin	13.09%	20.93%	33.84%	11.75%	9.55%
Free Cash Flow Per Share	18.79	30.20	45.93	18.02	15.46
Cash Interest Paid	-	0.1	0.1	0.5	0.4
Cash Income Tax Paid	352.6	162.9	-382.7	-23.4	185.9
Levered Free Cash Flow	700.16	484.19	498.14	568.16	1,205
Unlevered Free Cash Flow	708.04	489	507.45	579.1	1,236
Change in Working Capital	-139.1	-7.6	90.4	-240	667.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.